Search

Displaying results 351 - 360 of 8415 in total
  1. Drug

    Brimonidine

    go.drugbank.com/drugs/DB00484
    ApprovedInvestigational

    [A178969] The ophthalmic solution of brimonidine was first approved by the FDA in 1996 as Alphagan [label] and brimonidine is the only selective alpha-adrenergic receptor agonist approved for chronic treatment … Brimonidine is an alpha-adrenergic agonist and 2-imidazoline derivative that was first introduced in 1996.

    Categories: Sympathomimetics Used as DecongestantsProducts: PMS-brimonidine
  2. Drug

    Lidocaine

    go.drugbank.com/drugs/DB00281
    ApprovedInvestigationalVet approved

    As a result, lidocaine is also considered a class Ib anti-arrhythmic agent [L5930, L5948, F4468]. … Ever since its discovery and availability for sale and use in the late 1940s, lidocaine has become an exceptionally commonly used medication [T583].

    Mixtures: GPL Pak, LP Lite PAKProducts: Lidotrans 5 Pak, DermacinRx PHN Pak
  3. Drug

    Leucovorin

    go.drugbank.com/drugs/DB00650
    ApprovedInvestigational

    Leucovorin, also known as folinic acid or citrovorum factor, is a reduced form of folic acid that serves as a vital coenzyme in nucleic acid synthesis. … [L56091, A257419] Leucovorin has been explored experimentally for autism spectrum disorder.[A275451, A275452]

    Products: Lederle Leucovorin-pws Im IV 50mg/vial, Lederle Leucovorin-pws Im IV 350mg/vial
  4. Drug

    Bupropion

    go.drugbank.com/drugs/DB01156
    ApprovedInvestigational

    [A6399,A178810] Bupropion was originally classified as an "atypical" antidepressant because it does not exert the same effects as the classical antidepressants such as Monoamine Oxidase Inhibitors ( … placebo, and was found to have similar rates of smoking cessation as [nicotine] replacement therapy (NRT).

    Products: PMS-bupropion SR
  5. Drug

    Bibrocathol

    go.drugbank.com/drugs/DB13818
    Investigational

    Products: Bibrocathol-POS 20 mg/g Augensalbe
  6. Drug

    Irbesartan

    go.drugbank.com/drugs/DB01029
    ApprovedInvestigational

    [L7456,L7459] Irbesartan was granted FDA approval on 30 September 1997.[L7456,L7459] … [L7456,L7459] It can also be used as part of a combination product with [hydrochlorothiazide] for patients not well controlled or not expected to be well controlled on monotherapy.

    Mixtures: PMS-irbesartan-hctz, PMS-irbesartan-hctzProducts: PMS-irbesartan, PMS-IRBESARTAN TABLET 300MG
  7. Target

    Hypoxia-inducible factor 1

    go.drugbank.com/bio_entities/BE0010297
    TargetHumans

    Transcription factor that functions as an obligate heterodimerization partner for several basic helix-loop-helix PER-ARNT-SIM (bHLH-PAS) proteins.

    Synonyms: Member of PAS protein 1, PAS domain-containing protein 8
  8. Drug

    Apomorphine

    go.drugbank.com/drugs/DB00714
    ApprovedInvestigational

    [A203618] Apomorphine has also been investigated as an emetic, a sedative, a treatment for alcoholism, and a treatment of other movement disorders. … It was first synthesized in 1845 and first used in Parkinson's disease in 1884.

    Products: APO-GO PFS 5MG/ML SC INFÜZYONLUK ÇÖZELTI IÇEREN KULLANIMA HAZIR ŞIRINGA, 5 ŞIRINGA
  9. Drug

    Mineral oil

    go.drugbank.com/drugs/DB11057
    ApprovedInvestigationalVet approved

    (PAC) can lead to skin cancer. … It is also used as a mild laxative for human or veterinary uses.

    Products: Pan Aromas Baby
  10. Drug

    Methylphenidate

    go.drugbank.com/drugs/DB00422
    ApprovedInvestigational

    Biphentin was designed to be an alternative to separate doses of immediate-release (IR) methylphenidate by providing a biphasic concentration-time profile when given as a single dose. … While its exact mechanism is unclear, methylphenidate (MPH) has been shown to act as a norepinephrine and dopamine reuptake inhibitor (NDRI), thereby increasing the presence of these neurotransmitters

    Products: PMS-methylphenidate, PMS-methylphenidate ER